Metastatic Cervical Carcinoma with High-Risk Human Papillomavirus (HPV) Positive and P16/ Ki-67 Positive in a 28 Year-Old Female That Did Not Meet the Current Screening Guidelines
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 2
Abstract
A case presentation about an individual treated at Oklahoma State University Medical Center with high-grade metastatic squamous cell carcinoma of the cervix that was high-risk HPV and p16/Ki-67 positive. The clinical presentation, laboratory data, imaging, and subsequent therapy are reported as well as highlights of screening guidelines for cervical pathology.
Authors and Affiliations
Stephenie Matosich
Giant Condyloma of the Uterus: MigratingDisease?
Genital Human papillomavirus (HPV) infection is the most common sexually transmitted infection. Although most infections are asymptomatic, a proportion of these infections will result in clinical symptoms. Giant condylom...
Hyperuricemia as a Predictor of Perinatal Outcomes in Pregnancy Induced Hypertension
Aim/Objective The aim of this study to determine the relationship between hyperuricemia and perinatal outcome in pregnancy induced hypertension. Material & Methods This prospective and observational study was carried out...
Etiology of Infection, Femoral Nerve and Splenic Injury by Abdominal Retractor
The aim of this work is to identify the underlying factors of infections in surgical wounds, as well as injury to the femoral nerve and spleen. Medical literature dating between the years 2000 and 2013 was reviewed using...
Doppler Indices of Uterine, Umbilical and Fetal Middle Cerebral Arteries Before and After Sildenafil Citrate and Transdermal Nitroglycerin in Cases Suffering from Intrauterine Growth Restriction
Introduction Intrauterine growth restriction (IUGR) is a major cause of perinatal morbidity and mortality. Its diagnosis and treatment constitute one of the most important challenges of present day obstetrics. A drug tha...
Pregnancy in Takayasu Arteritis Patients Exposed to Anti-Tumour Necrosis Factor (Anti-TNF)-α Therapy
Anti-TNF agents, IFX in particular,1 appear safe and effective in rheumatic patients during pregnancy. Here, we described two successful pregnancies of TA patients treated with IFX before conception and until 28 wg. Bloo...